Natalizumab for multiple sclerosis

N Engl J Med. 2007 Jun 21;356(25):2622-9. doi: 10.1056/NEJMct071462.
No abstract available

Publication types

  • Review

MeSH terms

  • Adult
  • Antibodies, Monoclonal / pharmacology
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Central Nervous System / immunology
  • Female
  • Humans
  • Integrin alpha4
  • Leukocytes, Mononuclear / drug effects
  • Multiple Sclerosis / drug therapy*
  • Multiple Sclerosis / immunology
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy
  • Natalizumab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Natalizumab
  • Integrin alpha4